{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"PDS Biotechnology Corporation"},"Symbol":{"label":"Symbol","value":"PDSB"},"Address":{"label":"Address","value":"300 CONNELL DRIVE,SUITE 4000, BERKELEY HEIGHTS, New Jersey, 07922, United States"},"Phone":{"label":"Phone","value":"+1 800 208-3343"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells."},"CompanyUrl":{"label":"Company Url","value":"https://www.pdsbiotech.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"David Schaaf","title":"Vice President-Medical Affairs"},{"name":"Frank K. Bedu-Addo","title":"President, Chief Executive Officer & Director"},{"name":"Gregory L. Conn","title":"Chief Scientific Officer"},{"name":"Joe J. Dervan","title":"Vice President-Research & Development"},{"name":"Kirk V. Shepard","title":"Chief Medical Officer"},{"name":"Stephan Toutain","title":"Chief Operations Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}